Literature DB >> 11834030

Aortic valve reimplantation in ascending aortic aneurysm: risk factors for early valve failure.

Klaus Pethig1, Andrea Milz, Christian Hagl, Wolfgang Harringer, Axel Haverich.   

Abstract

BACKGROUND: Aortic root reconstruction by reimplantation of the native valve represents a new therapeutic option for ascending aortic aneurysms. Information about long-term follow-up is limited, and possible predictors for failure of reconstruction have not been evaluated so far.
METHODS: After aortic valve reimplantation 101 patients were followed in a prospective observational study. From this cohort the first 75 consecutive patients with a complete 1-year follow-up were chosen for further analysis. Clinical and echocardiographic data were obtained preoperatively, intraoperatively, and early postoperatively, as well as after 1 year of follow-up.
RESULTS: No mortality was observed within the first 30 days. There were 52 male patients, mean age was 49.1+/-20.6 years, observation period was 35.6+/-20.6 months, and Marfan's syndrome was present in 22 patients. Although in 67 patients a stable valve function could be demonstrated, 5 patients presented with mild aortic insufficiency or had to be operated on again for secondary valve failure (n = 3). Analyzing possible demographic, disease-related, and procedure-related risk factors in a multivariable approach, only level of coaptation within the graft (as assessed by echocardiography) could be identified as being related to the subsequent development of aortic insufficiency. Coaptation level within the tube graft (type A) resulted in a mean aortic regurgitation grade of 0.3+/-0.5 as compared with a mean grade of 2.5+/-0.6 for a coaptation type C (below the prosthesis; p < 0.001).
CONCLUSIONS: Aortic valve reimplantation is a promising alternative to alloprosthetic composite replacement. A level of coaptation within the tube graft is essential to achieve valve competence.

Entities:  

Mesh:

Year:  2002        PMID: 11834030     DOI: 10.1016/s0003-4975(01)03312-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

1.  Long-term results after aortic valve-sparing operation (David I).

Authors:  Malakh Shrestha; Hassina Baraki; Ilona Maeding; Sebastian Fitzner; Samir Sarikouch; Nawid Khaladj; Christian Hagl; Axel Haverich
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

2.  Minimally invasive valve sparing aortic root replacement (David procedure) is safe.

Authors:  Malakh Shrestha; Heike Krueger; Julia Umminger; Nurbol Koigeldiyev; Erik Beckmann; Axel Haverich; Andreas Martens
Journal:  Ann Cardiothorac Surg       Date:  2015-03

3.  Aortic valve sparing operations: outcomes at 20 years.

Authors:  Tirone E David
Journal:  Ann Cardiothorac Surg       Date:  2013-01

4.  Complications after aortic valve repair and valve-sparing procedures.

Authors:  Michel Van Dyck; David Glineur; Laurent de Kerchove; Gébrine El Khoury
Journal:  Ann Cardiothorac Surg       Date:  2013-01

5.  Root remodeling for aortic root dilatation.

Authors:  Hans-Joachim Schäfers; Diana Aicher
Journal:  Ann Cardiothorac Surg       Date:  2013-01

6.  Sparing aortic valve techniques.

Authors:  Rubén Álvarez-Cabo
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

Review 7.  Aortic valve repair update.

Authors:  Tatsuhiko Komiya
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-02-05

Review 8.  Toward standardization of valve-sparing root replacement and annuloplasty.

Authors:  Takashi Kunihara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-09-17

Review 9.  Aortic valve repair for aortic regurgitation and preoperative echocardiographic assessment.

Authors:  Takashi Kunihara
Journal:  J Med Ultrason (2001)       Date:  2018-09-19       Impact factor: 1.314

Review 10.  The role of transesophageal echocardiography in aortic valve preserving procedures.

Authors:  Terri Hall; Pallav Shah; Sudhir Wahi
Journal:  Indian Heart J       Date:  2014 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.